MAPT and Alzheimer disease: Although Aβ has long been considered the primary driver of AD pathogenesis, supported by genetic and biochemical evidence from amyloid precursor protein (APP) and presenilin mutations, accumulating research indicates that tau pathology is a critical determinant of synaptic dysfunction and cognitive decline [3].